Jefferies Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Jefferies Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,667	Closed	-$2.66M	–	3176
2015 Q2	$2.66M	Buy	+6,667	New	+$2.83M	0.01%	779
2015 Q1	–	Sell	-4,489	Closed	-$1.61M	–	2455
2014 Q4	$1.61M	Buy	4,489 +467	+12%	+$139K	0.01%	795
2014 Q3	$775K	Sell	4,022 -11,111	-73%	-$2.44M	0.01%	1120
2014 Q2	$3.62M	Buy	15,133 +5,133	+51%	+$1.04M	0.03%	432
2014 Q1	$2.56M	Buy	10,000 +6,667	+200%	+$2.04M	0.02%	526
2013 Q4	$660K	Buy	+3,333	New	+$593K	﹤0.01%	1017

Other funds holding LUMO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jefferies Group's LUMO Position: Q3 2022 in Review

Jefferies Group held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q3 2022 at 120,651 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #799.

Jefferies Group first reported a position in LUMO in Q4 2013 and has held it in 19 quarters since. The position peaked at $4.31M in Q4 2020. 35 funds tracked by Wall St. Rank hold LUMO as of Q3 2022.

Jefferies Group held 120,651 shares of Lumos Pharma, Inc. Common Stock worth $1.07M as of Q3 2022.
Jefferies Group left its Lumos Pharma, Inc. Common Stock share count unchanged in Q3 2022.
Lumos Pharma, Inc. Common Stock made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #799 holding.
Jefferies Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and has held it in 19 quarters since.
Jefferies Group's Lumos Pharma, Inc. Common Stock position peaked at $4.31M in Q4 2020.
35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.